The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AEROVATE THERAPEUTICS INC | COM | 008064107 | 2,994 | 191,565 | SH | OTR | 1 | 0 | 191,565 | 0 | |
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 16,398 | 1,926,869 | SH | OTR | 1 | 0 | 1,926,869 | 0 | |
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 26,164 | 2,831,588 | SH | OTR | 1 | 0 | 2,831,588 | 0 | |
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 7,640 | 2,589,679 | SH | OTR | 1 | 0 | 2,589,679 | 0 | |
| IMMUNIC INC | COM | 4525EP101 | 3,832 | 1,104,241 | SH | OTR | 1 | 0 | 1,104,241 | 0 | |
| KINNATE BIOPHARMA INC | COM | 49705R105 | 21,118 | 1,674,677 | SH | OTR | 1 | 0 | 1,674,677 | 0 | |
| MERUS N V | COM | N5749R100 | 22,668 | 1,001,217 | SH | OTR | 1 | 0 | 1,001,217 | 0 | |
| OTONOMY INC | COM | 68906L105 | 62 | 30,000 | SH | OTR | 1 | 0 | 30,000 | 0 | |
| PARDES BIOSCIENCES INC | COM | 69945Q105 | 6,694 | 2,180,560 | SH | OTR | 1 | 0 | 2,180,560 | 0 | |
| PASSAGE BIO INC | COM | 702712100 | 995 | 421,410 | SH | OTR | 1 | 0 | 421,410 | 0 | |
| PIERIS PHARMACEUTICALS INC | COM | 720795103 | 6,028 | 3,223,334 | SH | OTR | 1 | 0 | 3,223,334 | 0 | |
| THESEUS PHARMACEUTICALS INC | COM | 88369M101 | 2,792 | 504,862 | SH | OTR | 1 | 0 | 504,862 | 0 | |